Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4759601
Max Phase: Preclinical
Molecular Formula: C52H69N15O8
Molecular Weight: 1032.22
Molecule Type: Unknown
Associated Items:
ID: ALA4759601
Max Phase: Preclinical
Molecular Formula: C52H69N15O8
Molecular Weight: 1032.22
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@@](Cc1ccccc1)(NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)CCc1cccnc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O
Standard InChI: InChI=1S/C52H69N15O8/c1-52(30-32-11-3-2-4-12-32,66-46(72)40(62-43(69)22-20-33-13-7-23-59-31-33)28-34-19-21-35-14-5-6-15-36(35)27-34)49(75)65-38(17-9-25-61-51(57)58)48(74)67-26-10-18-41(67)47(73)63-37(16-8-24-60-50(55)56)45(71)64-39(44(54)70)29-42(53)68/h2-7,11-15,19,21,23,27,31,37-41H,8-10,16-18,20,22,24-26,28-30H2,1H3,(H2,53,68)(H2,54,70)(H,62,69)(H,63,73)(H,64,71)(H,65,75)(H,66,72)(H4,55,56,60)(H4,57,58,61)/t37-,38-,39-,40-,41-,52-/m0/s1
Standard InChI Key: OJAPGLNJFFPLKX-KJOQNZMSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1032.22 | Molecular Weight (Monoisotopic): 1031.5454 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Takayama K,Mori K,Asari T,Sohma Y,Nomura E,Sasaki Y,Taguchi A,Taniguchi A,Miyazato M,Minamino N,Kangawa K,Hayashi Y. (2020) Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability., 30 (18): [PMID:32721452] [10.1016/j.bmcl.2020.127436] |
Source(1):